Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research · 1 day ago
ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?Zacks Investment Research · 4 days ago
Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection TreatmentBusiness Wire · 4 days ago
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Akamai Technolgies, Apple, Blackrock, Ford Motor, Healthcare Realty Trust, Noble, Sunoco LP, Venture Global, Western Midstream Partners, Zoetis, and More247 Wallst · 5 days ago
8,293 Zoetis Inc. $ZTS Shares Sold by Banque Pictet & Cie SADefense World · Oct 17, 2026
Zoetis Appoints Iris Knobloch to its Board of DirectorsBusiness Wire · Oct 13, 2026Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | $1.85 | $1.87 | Beat |
| May 7, 2026 | $1.60 | $1.53 | Miss |
| Feb 12, 2026 | $1.40 | $1.48 | Beat |
| Nov 4, 2025 | $1.62 | $1.70 | Beat |
| Aug 5, 2025 | $1.62 | $1.76 | Beat |
| May 6, 2025 | $1.41 | $1.48 | Beat |